Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy.

PloS one

Volumn 8, Issue 8, 2013, Pages

  Kim, Yong Chul ^a   Chin, Ho Jun ^b   Koo, Ho Suk ^b   Kim, Suhnggwon ^b  

^a Seoul National University Hospital   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CREATININE; TACROLIMUS;

ADULT; ALBUMINURIA; BLOOD; BLOOD PRESSURE; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS, IGA; GLOMERULUS FILTRATION RATE; HUMAN; MALE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINE;

ADULT; ALBUMINURIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; CREATININE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; TACROLIMUS; TREATMENT OUTCOME;

EID: 84897923804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071545     Document Type: Article

References (0)